NCT00023413 TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz Status COMPLETED Phase PHASE2
NCT00023400 TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB Status COMPLETED Phase PHASE4
NCT00023387 TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine Status COMPLETED Phase NA
NCT00023374 TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance Status COMPLETED Phase NA
NCT00023361 TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen Status COMPLETED Phase NA
NCT00023348 TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB Status COMPLETED Phase PHASE2/PHASE3
NCT00018083 Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen Status UNKNOWN Phase NA
NCT00005741 Indigenous Outreach Among Injection Drug Users to Treat and Control TB Status COMPLETED Phase N/A
NCT00004740 Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users Status UNKNOWN Phase NA
NCT00004736 Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis Status COMPLETED Phase PHASE1
NCT00004276 Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections Status COMPLETED Phase PHASE2
NCT00000959 Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection Status COMPLETED Phase NA
NCT00000955 Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection Status COMPLETED Phase NA